Health-related quality of life, anxiety and depression in thyroid cancer patients under short-term hypothyroidism and TSH-suppressive levothyroxine treatment

European Journal of Endocrinology

Volumn 153, Issue 6, 2005, Pages 755-763

  Tagay, Sefik ^a   Herpertz, Stephan ^b   Langkafel, Matthias ^a   Erim, Yesim ^a   Freudenberg, Lutz ^b   Schöpper, Nicole ^a   Bockisch, Andreas ^a   Senf, Wolfgang ^a   Görges, Rainer ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131; LEVOTHYROXINE; THYROTROPIN;

ADULT; AGED; ANXIETY; ARTICLE; DEPRESSION; DOSE RESPONSE; DRUG WITHDRAWAL; FEMALE; GERMANY; HORMONAL THERAPY; HUMAN; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; QUALITY OF LIFE; RATING SCALE; SYMPTOMATOLOGY; THYROID CANCER;

ADULT; AFFECT; AGED; ANXIETY DISORDERS; CARCINOMA, PAPILLARY; CROSS-SECTIONAL STUDIES; DEPRESSION; FEMALE; HUMANS; HYPOTHYROIDISM; MALE; MIDDLE AGED; QUALITY OF LIFE; SUBSTANCE WITHDRAWAL SYNDROME; THYROID NEOPLASMS; THYROTROPIN; THYROXINE;

EID: 29644438614     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.1.02047     Document Type: Article

References (35)

1. Mazzaferri EL. An overview of the management of papillary and follicular thyroid carcinoma. Thyroid 1999 9 421-427.
2. Schlumberger M. Diagnostic follow up of well-differentiated thyroid carcinoma: historical perspective and current status. Journal of Endocrinological Investigation 1999 22 3-7.
3. Dow KH & Lafferty P. Quality of life, survivorship, and psychosocial adjustment of young women with breast cancer after breast-conserving surgery and radiation therapy. Oncology Nursing Forum 2000 27 1555-1564.
4. Meier CA, Braverman LE, Ebner SA, Veronikas I, Daniels GH, Ross DS, Deraska DJ, Davies TF, Valentine M, Degroot LJ, Curan P, McEllin K, Reynolds J, Robbins J & Weintraub BD. Diagnostic use of recombinant human thyrotropin in patients with thyroid carcinoma (Phase I/II Study). Journal of Clinical Endocrinology and Metabolism 1994 78 188-196.
5. Dow KH, Ferrell BR & Anello C. Quality-of-life changes in patients with thyroid cancer after withdrawal of thyroid hormone therapy. Thyroid 1977 7 613-619.
6. Dow K, Ferrell B & Anello C. Balancing demands of cancer surveillance among survivors of thyroid cancer. Cancer Practice 1997 5 289-294.
7. Dagan T, Bedrin L, Horowitz Z, Chaushu G, Wolf M, Kronenenberg J & Talmi Y. Quality of life of well-differentiated thyroid carcinoma patients. Journal of Laryngology and Otology 2004 118 537-542.
8. Haugen BR, Pacini F, Reiners C, Schlumberger M, Ladenson PW, Sherman SI, Cooper DS, Graham KE, Braverman LE, Skarulis MC, Davies TF, DeGroot LJ, Mazzaferri EL, Daniels GH, Ross DS, Luster M, Samuels MH, Becker DV, Mason HR 3rd, Cavalieri RR, Spencer CA, McEllin K, Weintraub BD & Ridgway EC. A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer. Journal of Clinical Endocrinology and Metabolism 1999 84 3877-3885.
9. Ware JE, Snow KK, Korinski M, Gandeck B. SF-36 Health Survey Manual and Interpretation Guide. Boston: New England Medical Center, The Health Institute, 1993.
10. Bullinger M, Kirschberger I & Ware JE. The German SF-36 Health Survey. Zeitschrift Gesundheitswissenschaft 1995 10 21-36.
11. Bullinger M, Kirschberger I. SF-36 Fragebogen zum Gesundheitszustand. Göttingen: Hogrefe, 1998.
12. Zigmond AS & Snaith RP. The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica 1983 67 361-370.
13. Herrmann C. International experiences with the hospital anxiety and depression scale - a review of validation data and clinical results. Journal of Psychosomatic Research 1997 42 17-41.
14. Beck AT, Ward CH, Mendelson M, Mock JE & Erbaugh JK. An inventory for measuring depression. Archives of General Psychiatry 1961 4 561-571.
15. McNair DM, Lorr M, Droppeleman LF. EITS Manual for the Profile of Mood States. San Diego CA: Educational and Industrial Testing Service, 1971.
16. Gotoy CC & Stern JD. Assessment of psychological functioning in cancer-patients. Journal of Psychosocial Oncology 1995 13 123-160.
17. Zulewski H, Müller B, Exer P, Miserez AR & Staub JJ. Estimation of tissue hypothyroidism by a new clinical score: evaluation of patients with various grades of hypothyroidism and controls. Journal of Clinical Endocrinology and Metabolism 1997 82 771-776.
18. Billewicz WZ, Chapman RS, Crooks J, Day ME, Gossage J, Wayne E & Young J. Statistical methods applied to the diagnosis of hypothyroidism. Quarterly Journal of Medicine 1969 150 255-266.
19. Görges R. The changing epidemiology of thyroid cancer. In Thyroid Cancer pp 3-27. Eds HJ Biersack & F Grünwald. Heidelberg: Springer, 2005.
20. Ladenson PW, Braverman LE, Mazzaferri EL, Brucker-Davis F, Cooper DS, Garber JR, Wondisford FE, Davies TF, DeGroot LJ, Daniels GH, Ross DS & Weintraub BD. Comparison of administration of recombinant human thyrotropin with withdrawal of thyroid hormone for radioactive iodine scanning in patients with thyroid carcinoma. New England Journal of Medicine 1997 337 888-896.
21. Botella-Carretero JI, Galán JM, Caballero C, Sanco J & Escobar-Morreale HF. Quality of life and psychometric functionality in patients with differentiated thyroid carcinoma. Endocrine-Related Cancer 2004 10 601-610.
22. Stajduhar KI, Neithercut J, Chu E, Pham P, Rohde J, Sicotte A & Young K. Thyroid cancer: patients' experiences of receiving iodine-131 therapy. Oncology Nursing Forum 2000 27 1213-1218.
23. Haggerty JJ, Stern RA, Mason GA, Beckwith J, Morey CE & Prange AJ. Subclinical hypothyroidism: a modifiable risk factor for depression? American Journal of Psychiatry 1993 150 508-510.
24. Dugbartey AT. Neurocognitive aspects of hypothyroidism. Archives of Internal Medicine 1998 158 1413-1418.
25. Maher EJ, Mackenzie C, Young T & Marks D. The use of the hospital anxiety and depression scale (HADS) and the EORTC QLQ-C30 questionnaire to screen for treatable unmet needs in patients attending routinely for radiotherapy. Cancer Treatment Reviews 1996 22 123-129.
26. Skarstein J, Aass N, Fossa S, Skovlund E & Dahl A. Anxiety and depression in cancer patients: relation between the hospital anxiety and depression scale and the European organization for research and treatment of cancer core quality of life questionnaire. Journal of Psychosomatic Research 2000 49 27-34.
27. Moorey S, Greer S, Watson M, Gorman C, Rowden L, Tunmore R, Robertson B & Bliss J. The factor structure and factor stability of the hospital anxiety and depression scale in patients with cancer. British Journal of Psychiatry 1991 158 255-259.
28. Fossa SD & Dahl AA. Short form 36 and hospital anxiety and depression scale - a comparison based on patients with testicular cancer. Journal of Psychosomatic Research 2002 52 79-87.
29. Monzani F, Del Guerra P, Caraccio N, Pruned CA, Pucci E, Luisi M & Baschieri L. Subclinical hypothyroidism: neurobehavioral features and beneficial effect of l-thyroxine treatment. Clinical Investigation 1993 71 367-371.
30. Baldini IM, Vita A, Mauri CM, Amodei V, Carrisi M, Bravin S & Cantalamessa L. Psychopathological and cognitive features in Subclinical hypotyhroidism. Progress in Neuro-Psychopharmacology and Biological Psychiatry 1997 21 925-935.
31. Engum M, Bjoro T, Mykletun A & Dahl AA. An association between depression, anxiety and thyroid function - a clinical fact or artifact? Acta Psychiatrica Scandinavica 2002 106 27-34.
32. Demet NM, Ozmen B, Deveci A, Boyvada S, Adiguzel H & Aydemir O. Depression and anxiety in hypotyhroidism. West Indian Medical Journal 2003 52 223-227.
33. Crevenna R, Zettinig G, Keilani M, Posch M, Schmidinger M, Pirich C, Nuhr M, Wolzt M, Quittan M, Fialka-Moser V & Dudczak R. Quality of life in patients with non-metastatic differentiated thyroid cancer under thyroxine supplementation therapy. Support Care Cancer 2004 11 597-603.
34. Schultz PN, Stava C & Vassilopoulou-Sellin R. Health profiles and quality of life of 518 survivors of thyroid cancer. Head and Neck 2003 25 349-356.
35. Testa MA. A pilot study of life-outcomes. European Journal of Medicine 2000 9 230-234.